Point of Care Diagnostics Market: Growth, Share & Forecasts
- The global point of care diagnostics market is experiencing important growth, fueled by the increasing prevalence of infectious diseases and improved online access to diagnostic tools.
- Point of care diagnostics offer rapid results, crucial for managing infectious diseases, especially in regions with limited healthcare access.
- Glucose monitoring products currently hold a substantial share of the point of care diagnostics market, driven by increased availability of devices, rising diabetes rates, and a shift toward...
The point of care diagnostics market is booming, considerably spurred by the escalating prevalence of infectious diseases. Respiratory illnesses like COVID-19 and influenza are key drivers of this expansion, making rapid diagnostics essential. Glucose monitoring products currently dominate the market, thanks to rising diabetes rates and a move to home healthcare solutions. the asia-Pacific region leads in growth, with an expected 18.8% CAGR by 2025,fueled by government initiatives. Explore how this growth impacts major players such as Roche Diagnostics and Abbott. For more insights into the sector, check out News Directory 3. Discover what’s next in the world of rapid and accessible diagnostic solutions.
Point of Care Diagnostics Market Sees Growth Amid Infectious Disease Surge
Updated June 1, 2025
The global point of care diagnostics market is experiencing important growth, fueled by the increasing prevalence of infectious diseases and improved online access to diagnostic tools. Respiratory illnesses, including COVID-19 and influenza, are major contributors to this surge.
Point of care diagnostics offer rapid results, crucial for managing infectious diseases, especially in regions with limited healthcare access. UNAIDS data indicates a high prevalence of HIV in East and Southern Africa, as well as in the Asia Pacific region, driving demand for rapid diagnostics.
Glucose monitoring products currently hold a substantial share of the point of care diagnostics market, driven by increased availability of devices, rising diabetes rates, and a shift toward home healthcare.
The Asia Pacific region is poised to be the fastest-growing market, with a projected CAGR of 18.8% from 2020 to 2025.Government initiatives,growing awareness of self-testing,and increasing collaborations among key players are driving this expansion.
Key players in the point of care diagnostics market include Roche Diagnostics, Abbott laboratories, and Siemens Healthineers. These companies are expanding thier manufacturing facilities across north America and Europe to meet the rising demand.
what’s next
the point of care diagnostics market is expected to continue its upward trajectory, driven by technological advancements and increasing demand for rapid and accessible diagnostic solutions. Focus will likely be on developing more refined and user-pleasant devices for home use and remote healthcare settings.